文献
J-GLOBAL ID:201702235405376701
整理番号:17A1172646
再発性または進行性非小細胞肺癌患者を研究2相IIのニボルマブ誘導間質性肺疾患解析【Powered by NICT】
Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
著者 (13件):
Kato Terufumi
(Kanagawa Cancer Center, Kanagawa, Japan)
,
Masuda Noriyuki
(Kitasato University Hospital, Kanagawa, Japan)
,
Nakanishi Yoichi
(Kyushu University Hospital, Fukuoka, Japan)
,
Takahashi Masashi
(Yamazaki Hospital, Shiga, Japan)
,
Hida Toyoaki
(Aichi Cancer Center Hospital, Aichi, Japan)
,
Sakai Hiroshi
(Saitama Cancer Center, Saitama, Japan)
,
Atagi Shinji
(Kinki-chuo Chest Medical Center, Osaka, Japan)
,
Fujita Shiro
(Institute of Biomedical Research and Innovation, Hyogo, Japan)
,
Tanaka Hiroshi
(Niigata Cancer Center Hospital, Niigata, Japan)
,
Takeda Koji
(Osaka City General Hospital, Osaka, Japan)
,
Satouchi Miyako
(Hyogo Cancer Center, Hyogo, Japan)
,
Namba Yoshinobu
(ONO Pharmaceutical Co., Ltd., Osaka, Japan)
,
Tamura Tomohide
(St. Luke’s International Hospital, Tokyo, Japan)
資料名:
Lung Cancer
(Lung Cancer)
巻:
104
ページ:
111-118
発行年:
2017年
JST資料番号:
W3184A
ISSN:
0169-5002
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)